Search research articles
Contact Us
Filters
Showing results (141-150 of 176) with videos related to
Page
of 18
Sort By:
Annals of Neurology
|
February 5, 1998
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease
I Zerr, M Bodemer, O Gefeller, et al.
Journal of Neuroimmunology
|
February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis
P Rieckmann, F Weber, A Günther, et al.
Neuron
|
November 10, 1998
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation
S Impey, K Obrietan, S T Wong, et al.
Journal of Neurology
|
November 14, 1997
S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto, H Stein, A Szudra, et al.
Journal of Neuroimmunology
|
November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
J Brettschneider, D Ecker, A Bitsch, et al.
Acta Neurologica Scandinavica
|
March 1, 1992
Early prognostic factors for disability in multiple sclerosis, a European multicenter study
T Riise, M Grønning, O Fernández, et al.
Human Genetics
|
September 15, 2000
Molecular genetics of human prion diseases in Germany
O Windl, A Giese, W Schulz-Schaeffer, et al.
Neurology
|
August 28, 2002
Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls
H J T Ward, D Everington, E A Croes, et al.
Journal of Neuroimmunology
|
February 13, 2001
Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis
H Hackstein, A Bitsch, A Bohnert, et al.
Archives of Neurology
|
January 29, 1999
The Heidenhain variant of Creutzfeldt-Jakob disease
S Kropp, W J Schulz-Schaeffer, M Finkenstaedt, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 176) with videos related to
Sort By:
Page
of 18
Annals of Neurology
|
February 5, 1998
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease
I Zerr, M Bodemer, O Gefeller, et al.
Journal of Neuroimmunology
|
February 1, 1996
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis
P Rieckmann, F Weber, A Günther, et al.
Neuron
|
November 10, 1998
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation
S Impey, K Obrietan, S T Wong, et al.
Journal of Neurology
|
November 14, 1997
S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto, H Stein, A Szudra, et al.
Journal of Neuroimmunology
|
November 26, 2002
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b
J Brettschneider, D Ecker, A Bitsch, et al.
Acta Neurologica Scandinavica
|
March 1, 1992
Early prognostic factors for disability in multiple sclerosis, a European multicenter study
T Riise, M Grønning, O Fernández, et al.
Human Genetics
|
September 15, 2000
Molecular genetics of human prion diseases in Germany
O Windl, A Giese, W Schulz-Schaeffer, et al.
Neurology
|
August 28, 2002
Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls
H J T Ward, D Everington, E A Croes, et al.
Journal of Neuroimmunology
|
February 13, 2001
Analysis of interleukin-4 receptor alpha chain variants in multiple sclerosis
H Hackstein, A Bitsch, A Bohnert, et al.
Archives of Neurology
|
January 29, 1999
The Heidenhain variant of Creutzfeldt-Jakob disease
S Kropp, W J Schulz-Schaeffer, M Finkenstaedt, et al.
Page
of 18